Caption Management, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,127,802
+298.4%
228,300
+407.3%
0.02%
+450.0%
Q4 2022$283,050
-85.4%
45,000
-39.7%
0.00%
-84.0%
Q2 2021$1,944,000
-8.2%
74,600
+24.3%
0.02%
-45.7%
Q1 2021$2,118,000
-67.9%
60,000
-61.0%
0.05%
-79.0%
Q2 2020$6,591,000
+405.4%
153,900
+129.7%
0.22%
+200.0%
Q1 2020$1,304,000
-36.1%
67,000
-14.6%
0.07%
+7.4%
Q4 2019$2,040,000
-2.9%
78,455
+1.9%
0.07%
-37.6%
Q3 2019$2,101,00077,0000.11%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$45,386,0009.32%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$472,400,0005.23%
Wildcat Capital Management, LLC 1,515,524$38,252,0004.81%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 900,143$22,720,0003.28%
Coastal Bridge Advisors, LLC 385,824$9,738,0001.93%
Casdin Capital, LLC 945,000$23,852,0000.71%
DSAM Partners (London) Ltd 208,798$5,270,0000.62%
BAINCO INTERNATIONAL INVESTORS 152,839$3,858,0000.44%
Pier Capital, LLC 152,071$3,838,0000.41%
Woodline Partners LP 567,539$14,325,0000.38%
View complete list of ALLOGENE THERAPEUTICS INC shareholders